Inactive Instrument

Highlights Nuvo Pharmaceuticals Inc.

Equities

MRV

CA67092F1045

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Searchlight Pharma Inc. completed the acquisition of Nuvo Pharmaceuticals Inc. from Red Oak Partners, LLC and other shareholders.	13/03/23	CI
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare Brief: Obtained Friday Final Order Approving Plan of Arrangement Related To Acquisition by Searchlight Pharma Inc.	13/03/23	MT
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare Brief: Announcing Shareholder Approval of Plan of Arrangement Related To Acquisition by Searchlight Pharma Inc.	07/03/23	MT
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare Up 88% After Entering into Definitive Agreement to be Acquired by Searchlight Pharma Inc.	28/12/22	MT
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare Entered into Definitive Agreement to be Acquired by Searchlight Pharma Inc.	28/12/22	MT
Searchlight Pharma Inc. entered into a definitive agreement to acquire Nuvo Pharmaceuticals Inc. from Red Oak Partners, LLC and other shareholders for CAD 15.4 million.	22/12/22	CI
Miravo Healthcare Reports Q3 Results, Says Canadian Commercial Business Segment Continues to Grow	14/11/22	MT
Nuvo Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
Earnings Flash (MRV) NUVO PHARMACEUTICALS Reports Q3 Revenue $18.1M	14/11/22	MT
Nuvo Pharmaceuticals Seeks Acquisitions	15/08/22	CI
Miravo Healthcare Higher as Announces Q2 Revenue of $20.9 Million; to Wind Down Pennsaid 2% Quebec Facility	15/08/22	MT
Nuvo Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/08/22	CI
Miravo Healthcare Brief: Q2 Total Revenue was C$20.9 Million; Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare	15/08/22	MT
Nuvo Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22	CI
Nuvo Pharmaceuticals Inc. Provides an Update on the United States Pennsaid® 2% Business	12/05/22	CI
Nuvo Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	28/03/22	CI
Miravo Healthcare Announces Canadian Commercial Launch of Blexten	01/03/22	MT
Miravo Healthcare Announces Summary Judgment Ruling by United States District Court for District of New Jersey	28/02/22	MT
Nuvo Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21	CI
Earnings Flash (MRV) NUVO PHARMACEUTICALS Reports Q3 Revenue $17.1M	15/11/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Nuvo Pharmaceuticals Inc.

Equities

MRV

CA67092F1045

Highlights

Filters